From October 1, 2022 to November 21, 2022, the company has repurchased 1,211,505 shares, representing 0.22% for CNY 55.98 million. With this, the company has completed the repurchase of 2,022,344 shares, representing 0.37% for CNY 100 million under the buyback announced on August 4, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.32 CNY | +0.14% | -5.67% | -43.06% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.06% | 1.08B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.55% | 246B | |
+10.78% | 213B | |
-3.11% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.